Cargando…
Prevention of maternal cytomegalovirus infection: current status and future prospects
Human cytomegalovirus (CMV) infection is the most common cause of perinatal viral infection in the developed world, resulting in approximately 40,000 congenitally infected infants in the United States each year. Congenital CMV infection can produce varying degrees of neurodevelopmental disabilities....
Autores principales: | Nyholm, Jessica L, Schleiss, Mark R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971724/ https://www.ncbi.nlm.nih.gov/pubmed/21072294 |
Ejemplares similares
-
Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
por: Schleiss, Mark R.
Publicado: (2013) -
Cytomegalovirus vaccines under clinical development
por: Schleiss, Mark R
Publicado: (2016) -
Awareness of congenital cytomegalovirus and acceptance of maternal and newborn screening
por: Tastad, Katie J., et al.
Publicado: (2019) -
Development and Assessment of a Prenatal Cytomegalovirus (CMV) Educational Survey: Implementation and Impact in a Metropolitan University-Based Clinic
por: Schaefer, Malinda R, et al.
Publicado: (2020) -
Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model
por: Schleiss, Mark R, et al.
Publicado: (2006)